Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Quarterly Financial Performance and Results
BDX logo

BD Reports 5.2% Revenue Growth Amid Major Strategic Spin-Off and $450 Million Impairment Charge

BDX10-QFiling Date: 5/7/2026
Becton, Dickinson and Company
Description

What this story covers

BD's latest filing reveals 5.2% revenue growth to $4.714 billion, driven by volume and reorganization. Despite regulatory challenges and restructuring costs, the company maintains strong liquidity and shareholder returns.

Story snapshot

CompanyBecton, Dickinson and Company
TickerBDX
VariantStandard detailed
Duration13:27
Filing type10-Q
PeriodQ4 2026
IndustryHealthcare & Pharmaceuticals
Accession0000010795-26-000026
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in